换一批
换一批Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.
第一作者：
Marek,Hus
第一单位：
Department of Haematology and Bone Marrow Transplantation, Medical University of Lublin, Staszica 11, Lublin, Poland. markhus@o2.pl
作者：
主题词
老年人(Aged);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);地塞米松(Dexamethasone);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);羟甲基戊二酰基CoA还原酶抑制剂(Hydroxymethylglutaryl-CoA Reductase Inhibitors);免疫调节(Immunomodulation);免疫抑制剂(Immunosuppressive Agents);洛伐他汀(Lovastatin);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);肿瘤复发, 局部(Neoplasm Recurrence, Local);挽救疗法(Salvage Therapy);干细胞移植(Stem Cell Transplantation);存活率分析(Survival Analysis);沙立度胺(Thalidomide);移植, 自体(Transplantation, Autologous)
DOI
10.1007/s00277-011-1276-2
PMID
21698395
发布时间
2021-10-20
- 浏览20
Annals of hematology
1161-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
